Biocartis Group NV: Biocartis Q1 2016 Business Update
Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics company (Euronext Brussels: BCART…
Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics company (Euronext Brussels: BCART…
Curetis N.V. (the "Company" and, together with Curetis GmbH, "Curetis"), a developer of next-level molecular diagnostic…
Curetis N.V. (the "Company" and, together with Curetis GmbH, "Curetis"), a developer of next-level molecular diagnostic…
Curetis N.V. (the "Company" and, together with Curetis AG, "Curetis"), a developer of next-level molecular diagnostic so…
Curetis B.V.[1] (the "Company") and, together with Curetis AG, "Curetis"), a developer of next-level molecular diagnosti…
Scientists of Charité - Universitätsmedizin Berlin and NOXXON Pharma are invited to present new preclinical data about e…
ZZ Biotech today announced that the National Institutes of Health will support a multicenter Phase 2 clinical trial of i…
Humedics GmbH, a specialist for real-time and mobile measurement of the individual liver function at the bedside of the…
Ascenion GmbH congratulates Prof. Klaus Brandenburg, scientist at the Research Center Borstel - Leibniz Center for Medic…
The German Biotechnology company SIRS-Lab requested the opening of insolvency proceedings. The company, founded ten year…